Primary Cells Market Size, Share, Analysis, Trends, Growth, 2032

Primary Cells Market

Primary Cells Market - By Origin (Hematopoietic Cells, Renal Cells, Skin Cells, Lung Cells, Gastrointestinal Cells, Heart, Liver Cells, Skeletal And Muscle Cells, And Other Primary Cells), By Type (Human Primary Cells And Animal Primary Cells), And By End-User (Life Science Research Companies And Research Institutes) By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 – 2032

Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-3689 Published Date: Mar-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.88 Billion USD 6.77 Billion 9.97% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Primary Cells Market, 2017 - 2024 (USD Billion)
    • 2.2. Global Primary Cells Market: Snapshot
  •  
  • Chapter 3. Primary Cells Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Primary Cells Market drivers: Impact analysis
      • 3.2.2. Increasing Cancer Research
      • 3.2.3. Advantages of Primary Human Cells Over Cell Lines
    • 3.3. Market Restraints
      • 3.3.1. Concerns Regarding Primary Cell Culture Contamination
    • 3.4. Opportunities
      • 3.4.1. Advancing Biomedical Research Using Primary Cells in 3D Culture
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Origin
      • 3.6.2. Market attractiveness analysis, by Type
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Regional Segment
  •  
  • Chapter 4. Global Primary Cells Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Primary Cells Market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Primary Cells Market - Origin Segment Analysis
    • 5.1. Global Primary Cells Market: Origin overview
      • 5.1.1. Global Primary Cells Market revenue share, by Origin, 2017 and 2024(USD Billion)
    • 5.2. Hematopoietic Cells
      • 5.2.1. Global Hematopoietic Cells market, 2017 - 2024(USD Billion)
    • 5.3. Skin Cells
      • 5.3.1. Global Skin Cells market, 2017 - 2024(USD Billion)
    • 5.4. Gastrointestinal Cells
      • 5.4.1. Global Gastrointestinal Cells market, 2017 - 2024(USD Billion)
    • 5.5. Liver Cells
      • 5.5.1. Global Liver Cells market, 2017 - 2024(USD Billion)
    • 5.6. Lung Cells
      • 5.6.1. Global Lung Cells market, 2017 - 2024(USD Billion)
    • 5.7. Renal Cells
      • 5.7.1. Global Renal Cells market, 2017 - 2024(USD Billion)
    • 5.8. Heart
      • 5.8.1. Global Heart market, 2017 - 2024(USD Billion)
    • 5.9. Skeletal and Muscle Cells
      • 5.9.1. Global Skeletal and Muscle Cells market, 2017 - 2024(USD Billion)
    • 5.10. Other Primary Cells
      • 5.10.1. Global Other Primary Cells market, 2017 - 2024(USD Billion)
  •  
  • Chapter 6. Global Primary Cells Market - Type Segment Analysis
    • 6.1. Global Primary Cells Market: Type overview
      • 6.1.1. Global Primary Cells Market revenue share, by Type, 2017 and 2024(USD Billion)
    • 6.2. Human Primary Cells
      • 6.2.1. Global Primary Cells Market for Human Primary Cells, 2017 - 2024(USD Billion)
    • 6.3. Animal Primary Cells
      • 6.3.1. Global Primary Cells Market for Animal Primary Cells, 2017 - 2024(USD Billion)
  •  
  • Chapter 7. Global Primary Cells Market - End-User Segment Analysis
    • 7.1. Global Primary Cells Market: End-User overview
      • 7.1.1. Global Primary Cells Market revenue share, by End-User, 2017 and 2024(USD Billion)
    • 7.2. Life Science Research Companies
      • 7.2.1. Global Primary Cells Market for Life Science Research Companies, 2017 - 2024(USD Billion)
    • 7.3. Research Institutes
      • 7.3.1. Global Primary Cells Market for Research Institutes, 2017 - 2024(USD Billion)
  •  
  • Chapter 8. Global Primary Cells Market - Regional Segment Analysis
    • 8.1. Global Primary Cells Market: Regional overview
      • 8.1.1. Global Primary Cells Market revenue share, by Region, 2015 and 2021
    • 8.2. North America
      • 8.2.1. North America Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.2.2. North America Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
      • 8.2.3. North America Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.2.4.2. The U.S. Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.2.4.3. The U.S. Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.2.5.2. Rest of North America Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.2.5.3. Rest of North America Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.3.2. Europe Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
      • 8.3.3. Europe Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.3.4.2. Germany Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.3.4.3. Germany Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.3.5.2. UK Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.3.5.3. UK Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.3.6.2. France Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.3.6.3. France Primary Cells Market revenue, by End-User, 2017-2024(USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.3.7.2. Rest of Europe Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.3.7.3. Rest of Europe Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.4.2. Asia Pacific Primary Cells Market revenue, Type, 2017 - 2024(USD Billion)
      • 8.4.3. Asia Pacific Primary Cells Market revenue, End-User, 2017 - 2024(USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.4.4.2. China Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.4.4.3. China Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.4.5.2. Japan Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.4.5.3. Japan Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.4.6.2. India Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.4.6.3. India Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.5.2. Latin America Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
      • 8.5.3. Latin America Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.5.4.2. Brazil Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.5.4.3. Brazil Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.5.5.2. Rest of Latin America Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.5.5.3. Rest of Latin America Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.6.2. The Middle East and Africa Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
      • 8.6.3. The Middle East and Africa Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Thermo Fisher Scientific
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Merck KGaA
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Lonza
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Cell Biologics
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. PromoCell
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. ZenBio
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. STEMCELL Technologies
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. AllCells
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. American Type Culture Collection
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Axol Biosciences
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global Primary Cells Market revenue, 2017 – 2024 (USD Billion) 
4. Porter’s Five Forces analysis
5. Primary Cells Market attractiveness analysis, by Origin segment
6. Primary Cells Market attractiveness analysis, by Type
7. Primary Cells Market attractiveness analysis, by End-User
8. Primary Cells Market: Market attractiveness analysis, by region
9. Company market share analysis, 2015
10. Global Primary Cells Market revenue share by Product, 2017 and 2024
11. Global Primary Cells Market, 2017 – 2024 (USD Billion)
a. Global Hematopoietic Cells market, 2017 – 2024(USD Billion)
b. Global Skin Cells market, 2017 – 2024(USD Billion)
c. Global Gastrointestinal Cells market, 2017 – 2024(USD Billion)
d. Global Liver Cells market, 2017 – 2024(USD Billion)
e. Global Lung Cells market, 2017 – 2024(USD Billion)
f. Global Renal Cells market, 2017 – 2024(USD Billion)
g. Global Heart market, 2017 – 2024(USD Billion)
h. Global Skeletal and Muscle Cells market, 2017 – 2024(USD Billion)
i. Global Other Primary Cells market, 2017 – 2024(USD Billion)
12. Global Primary Cells Market revenue share by Type, 2017 and 2024
13. Global Primary Cells Market, 2017 – 2024 (USD Billion)
a. Human Primary Cells, 2017 – 2024(USD Billion)
b. Animal Primary Cells, 2017 – 2024(USD Billion)
14. Global Primary Cells Market revenue share by End-User, 2017 and 2024
15. Global Primary Cells Market, 2017 – 2024 (USD Billion)
a. Life Science Research Companies, 2017 – 2024(USD Billion)
b. Research Institutes, 2017 – 2024(USD Billion)


Table Of Tables

List of Tables

1. Primary Cells Market: Market Snapshot                                                                                                                        
2. Drivers of global Primary Cells Market: Impact analysis 
3. Restraints of Primary Cells Market: Impact analysis
4. North America Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
5. North America Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
6. North America Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion) 
7. The U.S. Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
8. The U.S. Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
9. The U.S. Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
10. Rest of North America Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
11. Rest of North America Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
12. Rest of North America Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
13. Europe Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
14. Europe Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
15. Europe Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
16. Germany Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
17. Germany Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
18. Germany Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
19. UK Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
20. UK Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
21. UK Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
22. France Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
23. France Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
24. France Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion) 
25. Rest of Europe Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
26. Rest of Europe Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
27. Rest of Europe Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
28. Asia Pacific Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
29. Asia Pacific Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
30. Asia Pacific Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
31. China Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
32. China Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
33. China Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
34. Japan Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
35. Japan Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
36. Japan Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
37. India Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
38. India Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
39. India Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
40. Rest of Asia Pacific Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
41. Rest of Asia Pacific Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
42. Rest of Asia Pacific Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
43. Latin America Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
44. Latin America Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
45. Latin America Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
46. Brazil Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
47. Brazil Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
48. Brazil Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion) 
49. Rest of Latin America Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
50. Rest of Latin America Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
51. Rest of Latin America Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion) 
52. The Middle East and Africa Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
53. The Middle East and Africa Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
54. The Middle East and Africa Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)

Methodology

FrequentlyAsked Questions

Primary cells are isolated from living organisms including humans, animals, and plants and have not been cultured or immortalized. These cells are useful for drug development, disease modeling, and toxicity testing since they preserve their physiological capabilities. Primary cells better simulate in vivo settings than cell lines derived from continuous culture, allowing researchers to achieve more precise experimental results. Primary cells are widely used in cell biology, regenerative medicine, and cancer research due to their biological value.

Rapid growth in the biotechnology and biopharmaceutical industries, advantages of primary human cells over cell lines, increased demand for monoclonal antibodies, and partnerships, collaborations, and acquisitions are likely to drive the global primary cells market in the upcoming years.

According to the report, the global primary cells market size was worth around USD 2.88 billion in 2023 and is predicted to grow to around USD 6.77 billion by 2032.

The global primary cells market is expected to grow at a CAGR of 9.97% during the forecast period.

North America is projected to lead the primary cells market globally. The rising occurrences of cancer and the expansion of pharmaceutical and biotechnology industries in the region are the major factors driving the growth of the primary cells market in North America.

Few of the key players in primary cells market include Thermo Fisher Scientific, Merck KGaA, Lonza, Cell Biologics, PromoCell, ZenBio, STEMCELL Technologies, AllCells, American Type Culture Collection, and Axol Biosciences, among others.

The global primary cells market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed